The Center for Microbiome Sciences & Therapeutics (CMiST), part of the UW Medicine’s Department of Medicine and Division of Gastroenterology, is a scientific research center committed to understanding the dynamic interactions between the microbiome and our own human cells, to advancing the development of microbiome-based biotherapeutics to treat or prevent disease and to educating the community about the importance of the microbiome in maintaining a healthy lifestyle. To accomplish these goals, CMiST has established a world class team of clinicians, scientists and educators that span biomedical and basic science departments as well as the arts.
With access to a brand new germ-free animal facility, Innovations Services devoted to understanding host-microbial and microbial-microbial interactions, and an environment that promotes scientific rigor, fosters creativity, believes in the value of arts in science and celebrates out-of-the-box thinking, CMiST will be a beacon for translational microbiome research. For additional information about CMiST and the Innovation Services we offer, visit our website at www.cmistuw.org or email us at firstname.lastname@example.org. If you would like to learn more about our director, William DePaolo, or are interested in a scientific or artistic collaboration, please email email@example.com or visit our laboratory website at www.depaololab.com.
R. William DePaolo
Associate Professor | Medicine
Lynn M. & Michael D. Garvey Endowed Chair | Gastroenterology
Director | Center for Microbiome Sciences & Therapeutics (CMiST)
Dr. William DePaolo, Will, is an Associate Professor of Medicine at the University of Washington Medical Center and is the recipient of the Lynn M. and Michael D. Garvey endowed chair in Gastroenterology.
Will was named Director of the Center for Microbiome Sciences & Therapeutics (CMiST). CMiST will serve as a beacon for investigators, clinicians and patients interested in the human microbiome, and will offer a number of Innovation Services, facilitate collaboration and exploration through workshops and seminar series, and work alongside clinicians to develop and test microbiome-derived therapeutics.
In 2004, Will received his PhD in Immunology & Microbial Pathogenesis from the Feinberg School of Medicine of Northwestern University. Will then completed his postdoctoral training at the University of Chicago where he investigated the molecular pathogenesis of Yersinia pestis, the bacterium that causes bubonic plague, while concurrently developing projects investigating immune-modulation within the intestine. In 2011, Will joined the faculty at University of Southern California as an Assistant Professor in the Department of Molecular Microbiology and Immunology. Will combines his interdisciplinary training to investigate the contribution of our 100 trillion gut bacteria (or microbiome) to inflammatory diseases and to develop strategies aimed at manipulating this vast community. Will's current research extends across scientific disciplines and clinical diseases such as obesity, colon cancer, inflammatory bowel disease and enteric pathogens.